27 Feb 2013

UCB in 2012: New Core Medicines Drive Growth

Read More
26 Feb 2013

UCB to license worldwide rights to tozadenant in Parkinson’s disease from Biotie Therapies

Read More
21 Feb 2013

UCB and ConfometRx announce new R&D partnership

Read More
20 Feb 2013

UCB announces regulatory filings for Cimzia® (certolizumab pegol) to treat psoriatic arthritis and axial spondyloarthritis

Read More
11 Feb 2013

Acceleration of Fracture Healing with CDP7851/AMG785 will not move into phase 3

Read More
5 Feb 2013

UCB: Accelerating focus on the patient

Read More
4 Feb 2013

New single loading dose option for VIMPAT® (lacosamide) in the European Union allows for rapid initiation of adjunctive treatment in adults with partial onset seizures

Read More
25 Dec 2012

Neupro® (rotigotine transdermal patch) approved in Japan for Parkinson’s disease and Restless Legs Syndrome

Read More
25 Dec 2012

Astellas and UCB announce approval of Cimzia® (certolizumab pegol) in Japan for the treatment of adult patients with rheumatoid arthritis

Read More
19 Dec 2012

Welcome to UCB's media room

Read More
Subscribe to